The global hemodialysis and peritoneal dialysis market was valued at USD 102.1 billion in 2023 and is projected to reach USD 185.88 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030. Growth in this market is being driven by several critical factors, including the shortage of organ donors, the rising incidence of acute kidney injury (AKI), the risks associated with kidney transplants, and continuous technological advancements that are improving dialysis outcomes. Additionally, strategic initiatives by leading industry players to launch innovative products and advanced services are further propelling market expansion.

Chronic kidney disease (CKD) is a major factor influencing demand, as any condition that reduces kidney function over time can progress to End-Stage Renal Disease (ESRD), requiring dialysis or transplantation. The increasing prevalence of CKD globally is therefore expected to substantially drive the adoption of dialysis products and services.

For instance, according to the CDC’s 2023 report, approximately 35.5 million people in the U.S. are affected by CKD annually. Similarly, data from the National Institute of Diabetes and Digestive and Kidney Diseases (2022) indicated that 25,499 individuals in the U.S. underwent kidney transplants in that year. Despite this, the gap between transplant needs and organ availability underscores the necessity for dialysis treatments.

The growing burden of renal disease and renal failure is also strongly linked to the rising incidence of diabetes and hypertension, both of which are key risk factors. In particular, diabetic nephropathy, a complication of both type 1 and type 2 diabetes, damages the kidney’s blood vessel clusters responsible for filtering waste, ultimately resulting in renal impairment. For example, the 10th edition of the International Diabetes Federation (2022) reported that 5,141.3 thousand individuals in Spain had diabetes in 2021, illustrating the scale of the problem.

Moreover, according to the American Kidney Fund, Inc., in the U.S. alone, more than 562,000 people currently receive dialysis treatments, while over 245,000 individuals live with kidney transplants. These figures highlight the increasing reliance on dialysis as both a life-sustaining therapy and a critical alternative to transplantation, thereby reinforcing market growth.

Key Market Trends & Insights:

• In 2023, North America dominated the hemodialysis and peritoneal dialysis market, accounting for the largest revenue share of 38.25%. This regional leadership can be attributed to several factors, including the high prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), well-established healthcare infrastructure, favorable reimbursement policies, and the presence of leading industry players. Moreover, increased awareness of advanced treatment options and the growing adoption of home-based dialysis therapies are further supporting market expansion in the region.

• From an end-use perspective, the hospital-based segment emerged as the market leader, capturing a revenue share of 76.75% in 2023. Hospitals remain the primary point of care for dialysis treatments due to their access to specialized equipment, trained medical professionals, and the ability to handle complex cases and emergencies. The availability of comprehensive care facilities under one roof also ensures patient safety and treatment efficiency, contributing to the dominance of this segment.

• Based on product type, the service segment held the largest market share of 56.61% in 2023. This is largely driven by the recurring nature of dialysis procedures, which require continuous treatment sessions and ongoing monitoring. Services such as dialysis center management, patient support, and maintenance of dialysis systems play a crucial role in ensuring consistent and effective care. The rising patient pool, combined with increasing demand for both in-center and home dialysis services, has reinforced the leadership of this segment.

Order a free sample PDF of the Hemodialysis And Peritoneal Dialysis Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 102.1 Billion

• 2030 Projected Market Size: USD 185.88 Billion

• CAGR (2024-2030): 9.1%

• North America: Largest market in 2023

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Key players in the hemodialysis and peritoneal dialysis market are actively pursuing a range of growth strategies, including new product launches, securing regulatory approvals, geographic expansion, collaborations, acquisitions, and strategic partnerships. These initiatives are aimed at strengthening their market presence, broadening their product portfolios, and addressing the growing demand for advanced kidney care solutions.

A major area of focus for industry leaders is the enhancement of research and development (R&D) to drive innovation in dialysis technologies. For example, in April 2023, Outset Medical, Inc. introduced advancements with its Tablo Hemodialysis System, designed to reduce both the cost and complexity of dialysis treatment. The company also announced that it would present five new abstracts at the National Kidney Foundation Spring Clinical Meetings, covering critical topics such as the clinical and economic benefits of home hemodialysis (HHD), the issue of gender bias against female nephrologists, and other research findings relevant to kidney disease management.

Such initiatives highlight the industry’s commitment to improving patient outcomes, expanding accessibility, and reducing barriers to treatment. By leveraging innovation and addressing key clinical challenges, leading players are expected to accelerate the adoption of hemodialysis and peritoneal dialysis products, thereby driving strong market growth in the near future.

Key Players

• Baxter

• B. Braun SE

• Fresenius Medical Care AG

• Medtronic

• Asahi Kasei Medical Co., Ltd.

• Nipro Corp.

• DaVita

• BD

• Nikkiso Co., Ltd.

• Cantel Medical

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global hemodialysis and peritoneal dialysis market is poised for robust expansion, driven by ongoing technological advancements, the growing need for renal replacement therapies amid organ donation shortages, and a rising prevalence of chronic kidney disorders. Hospitals remain central to treatment delivery, while service offerings continue to dominate due to their recurring nature and comprehensive support. North America maintains premiere market leadership, benefiting from advanced infrastructure and favorable healthcare policies. Overall, strategic innovation by industry players coupled with demographic and clinical trends underpins a sustained upward trajectory for the sector.